CAM

Cormorant Asset Management Portfolio holdings

AUM $1.76B
1-Year Est. Return 415.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+415.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.47B
AUM Growth
+$32.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
127
New
Increased
Reduced
Closed

Top Buys

1
+$173M
2
+$75.9M
3
+$49.8M
4
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$43.3M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$42.5M

Top Sells

1
+$71.6M
2
+$51.4M
3
+$32.3M
4
CRSP icon
CRISPR Therapeutics
CRSP
+$30.6M
5
KURA icon
Kura Oncology
KURA
+$21.2M

Sector Composition

1 Healthcare 96.94%
2 Financials 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$396M 11.4%
6,411,355
2
$260M 7.49%
2,750,000
+357,703
3
$146M 4.22%
+5,114,850
4
$134M 3.85%
2,168,909
-96,853
5
$132M 3.81%
4,720,000
+260,000
6
$116M 3.34%
2,525,000
+29,934
7
$110M 3.17%
2,192,060
-100,000
8
$105M 3.03%
3,195,544
9
$92.1M 2.65%
2,490,065
10
$80.1M 2.31%
1,866,108
11
$74.3M 2.14%
+2,340,914
12
$65M 1.87%
881,770
13
$63.2M 1.82%
2,000,000
+800,000
14
$60.7M 1.75%
1,368,550
15
$58.7M 1.69%
3,300,030
-699,970
16
$55.8M 1.61%
1,437,807
17
$55.3M 1.59%
1,714,269
18
$53.8M 1.55%
2,464,545
-2
19
$50.4M 1.45%
+2,000,000
20
$47.1M 1.36%
275,000
-50,000
21
$45.3M 1.31%
+250,000
22
$43.6M 1.25%
850,000
-350,000
23
$41.5M 1.2%
693,000
24
$40.6M 1.17%
+800,000
25
$39.9M 1.15%
400,000
-100,000
1
2 3 4 5